Schizophrenia.com
FDA Approves VRAYLAR as Adjunctive Therapy for Major Depressive Disorder and AbbVie Announces Reimbursement Program in Canada
Medications
everhopeful
June 7, 2023, 2:14pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
AbbVie Announces Provincial Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia in Québec
Medications
1
292
April 17, 2023
Vraylar / cariprazine approved for MDD
News
2
275
December 17, 2022
AbbVie's VRAYLAR® (cariprazine) Receives Positive Reimbursement Recommendation by Canada's Drug Agency for the Treatment of Schizophrenia
Medications
0
30
September 4, 2024
AbbVie Submits Cariprazine FDA Application for Major Depressive Disorder
Medications
1
254
June 11, 2022
When will Vraylar become available in Canada?
DX'd - Other
13
744
November 17, 2020